Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-08 COUGHLIN TIMOTHY Director Grant or award +6,500 49,000
2024-05-08 COUGHLIN TIMOTHY Director Grant or award · Stock option (right to buy) +19,500 19,500
2024-05-08 Bruhn Suzanne Louise Director Grant or award +6,500 22,250
2024-05-08 Bruhn Suzanne Louise Director Grant or award · Stock option (right to buy) +19,500 19,500
2024-05-08 Baynes Roy D. Director Grant or award +6,500 31,000
2024-05-08 Baynes Roy D. Director Grant or award · Stock option (right to buy) +19,500 19,500
2024-04-11 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale −54 $6.74 $364 70,849
2024-02-01 Dube Eric M CHIEF EXECUTIVE OFFICER Sale −9,106 $8.53 $78K 360,616
2024-02-01 Dube Eric M CHIEF EXECUTIVE OFFICER Sale −10,016 $8.86 $89K 350,600
2024-02-01 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Sale −2,174 $8.53 $19K 83,310
2024-02-01 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Sale −2,590 $8.86 $23K 80,720
2024-02-01 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sale −2,174 $8.53 $19K 78,860
2024-02-01 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sale −2,590 $8.86 $23K 76,270
2024-02-01 Heerma Peter CHIEF COMMERCIAL OFFICER Sale −4,195 $8.53 $36K 99,503
2024-02-01 Inrig Jula CHIEF MEDICAL OFFICER Sale −2,174 $8.53 $19K 58,074
2024-02-01 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale −3,818 $8.53 $33K 70,903
2024-02-01 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale −2,820 $8.53 $24K 52,017
2024-01-31 Dube Eric M CHIEF EXECUTIVE OFFICER Grant or award +135,000 369,722
2024-01-31 Dube Eric M CHIEF EXECUTIVE OFFICER Grant or award · Employee stock option (right to buy) +360,000 360,000
2024-01-31 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Grant or award +25,000 85,484

Page 24 of 51 · 1,020 trades